Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study.
Willasch AM, Peters C, Sedláček P, Dalle JH, Kitra-Roussou V, Yesilipek A, Wachowiak J, Lankester A, Prete A, Hamidieh AA, Ifversen M, Buechner J, Kriván G, Hamladji RM, Diaz-de-Heredia C, Skorobogatova E, Michel G, Locatelli F, Bertaina A, Veys P, Dupont S, Or R, Güngör T, Aleinikova O, Sufliarska S, Sundin M, Rascon J, Kaare A, Nemet D, Fagioli F, Klingebiel TE, Styczynski J, Bierings M, Nagy K, Abecasis M, Afanasyev B, Ansari M, Vettenranta K, Alseraihy A, Chybicka A, Robinson S, Bertrand Y, Kupesiz A, Ghavamzadeh A, Campos A, Pichler H, Dalissier A, Labopin M, Corbacioglu S, Balduzzi A, Galimard JE, Bader P; EBMT Paediatric Diseases Working Party. Willasch AM, et al. Among authors: skorobogatova e. Bone Marrow Transplant. 2020 Aug;55(8):1540-1551. doi: 10.1038/s41409-020-0854-0. Epub 2020 Mar 17. Bone Marrow Transplant. 2020. PMID: 32203263 Free PMC article.
Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation.
Maschan AA, Kryzanovskii OI, Yourlova MI, Skorobogatova EV, Pashanov ED, Potapova YE, Timonova LA, Bogatcheva NY, Samochatova EV, Roumjantzev AG. Maschan AA, et al. Among authors: skorobogatova ev. Bone Marrow Transplant. 1997 Feb;19(4):385-7. doi: 10.1038/sj.bmt.1700662. Bone Marrow Transplant. 1997. PMID: 9051250
Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.
Maschan AA, Skorobogatova EV, Balashov DN, Pashanov ED, Trakhtman PE, Schipitzina IP, Skvortsova YV, Rumiantzev AG. Maschan AA, et al. Among authors: skorobogatova ev. Bone Marrow Transplant. 2002 Sep;30(6):405-7. doi: 10.1038/sj.bmt.1703668. Bone Marrow Transplant. 2002. PMID: 12235527
Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors.
Maschan AA, Trakhtman PE, Balashov DN, Shipicina IP, Skorobogatova EV, Skvortsova YV, Dyshlevaja ZM, Samochatova EV, Rumiantsev AG. Maschan AA, et al. Among authors: skorobogatova ev. Bone Marrow Transplant. 2004 Aug;34(4):305-7. doi: 10.1038/sj.bmt.1704580. Bone Marrow Transplant. 2004. PMID: 15195080
Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning.
Stepensky P, Shapira MY, Balashov D, Trakhtman P, Skorobogatova E, Rheingold L, Brooks R, Revel-Vilk S, Weintraub M, Stein J, Maschan A, Or R, Resnick IB. Stepensky P, et al. Among authors: skorobogatova e. Biol Blood Marrow Transplant. 2011 Sep;17(9):1282-8. doi: 10.1016/j.bbmt.2011.01.001. Epub 2011 Jan 8. Biol Blood Marrow Transplant. 2011. PMID: 21220033 Free article.
Recovery of ovarian function and pregnancy in a patient with AML after myeloablative busulphan-based conditioning regimen.
Balashov DN, Papusha LI, Nazarenko TA, Trakhtman PE, Revishvili NA, Maschan AA, Persiantseva MI, Andriutsa AV, Skorobogatova EV, Skvortsova YV, Rumiantsev AG. Balashov DN, et al. Among authors: skorobogatova ev. J Pediatr Hematol Oncol. 2011 May;33(4):e154-5. doi: 10.1097/MPH.0b013e3181faf7b5. J Pediatr Hematol Oncol. 2011. PMID: 21423042
Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita.
Fioredda F, Iacobelli S, Korthof ET, Knol C, van Biezen A, Bresters D, Veys P, Yoshimi A, Fagioli F, Mats B, Zecca M, Faraci M, Miano M, Arcuri L, Maschan M, O'Brien T, Diaz MA, Sevilla J, Smith O, Peffault de Latour R, de la Fuente J, Or R, Van Lint MT, Tolar J, Aljurf M, Fisher A, Skorobogatova EV, Diaz de Heredia C, Risitano A, Dalle JH, Sedláček P, Ghavamzadeh A, Dufour C. Fioredda F, et al. Br J Haematol. 2018 Oct;183(1):110-118. doi: 10.1111/bjh.15495. Epub 2018 Jul 9. Br J Haematol. 2018. PMID: 29984823 Free article.
36 results